Skip to main content
. 2019 Jul 24;14(7):e0212853. doi: 10.1371/journal.pone.0212853

Table 1. Comparison of basic demographic and clinical characteristics between pulmonary and extra-pulmonary tuberculosis patients.

Variables Total (N = 2771) PTB (N = 1121) EPTB (N = 1650) p-value
Gender (N, %)
    Males 1508 (54.4) 759 (67.7) 749 (45.4) <0.001μ*
    Females 1263 (45.6) 362 (32.3) 901 (54.6)
Age categories (years) (N, %)
    0–14 167 (6) 30 (2.7) 137 (8.3) <0.001 μ*
    15–59 2068 (74.6) 861 (76.8) 1207 (73.2) 0.035μ*
    ≥60 years 536 (19.4) 230 (20.5) 306 (18.5) 0.190 μ*
Residence (N, %)
    Rural 1144 (41.3) 496 (44.2) 648 (39.3) 0.009 μ*
    Urban 1627 (58.7) 625 (55.8) 1002 (60.7)
Treatment regimen
    Fixed dose combination (N, %) 732 (26.4) 317 (28.3) 415 (25.2) 0.067 μ*
    Separate tablets 2039 (73.6) 804 (71.7) 1235 (74.8)
Therapy duration (months) (Mean ± SD) 7.46 ± 4.3 6.6 ± 3.5 8 ± 4.6 <0.001 μ**
Disease outcomes (N, %)
    Relapse 10 (0.4) 3 (0.3) 7 (0.4) 0.700 μ*
    Death 79 (2.9) 41 (3.7) 38 (2.3) 0.035 μ*
    Treatment failure 5 (0.2) 4 (0.4) 1 (0.1) 0.100 μ*

N: Number; PTB: Pulmonary tuberculosis; EPTB: Extra-pulmonary tuberculosis; SD: Standard deviation

*: Chi-square test

**: t-test.

μ: p-value between PTB and EPTB.